Compare VOC & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOC | ICCC |
|---|---|---|
| Founded | 2010 | 1982 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.0M | 55.5M |
| IPO Year | N/A | N/A |
| Metric | VOC | ICCC |
|---|---|---|
| Price | $2.99 | $6.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 106.5K | 19.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 12.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $6.00 | $25.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.44 | $4.28 |
| 52 Week High | $3.88 | $7.60 |
| Indicator | VOC | ICCC |
|---|---|---|
| Relative Strength Index (RSI) | 53.59 | 49.13 |
| Support Level | $2.79 | $6.39 |
| Resistance Level | $3.29 | $6.78 |
| Average True Range (ATR) | 0.13 | 0.28 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 54.88 | 51.46 |
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.